Zymeworks (ZYME) Research Hub

Zymeworks (ZYME) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 28.37 USD (+0.53%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -17.06, market cap 1.73B. This hub links to the full technical, earnings and options research available for ZYME.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close28.37 USD (+0.53%)
52-week range21.8 USD – 31.34 USD
Trend regimeRange
14-day RSI64.8 (Bullish)
Trailing P/E-17.06
Market cap1.73B
Dividend yield0.00%
Next earnings2026-08-06

Available research for ZYME

Earnings

ZYME earnings date and last-quarter result: next report 2026-08-06, last quarter miss, P/E -17.06. Updated 2026-07-23.

Options: Covered Call

Covered Call on ZYME: how it works, illustrative setup around the real 28.37 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on ZYME: how it works, illustrative setup around the real 28.37 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on ZYME: how it works, illustrative setup around the real 28.37 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

ZYME technical analysis: range, last 28.37 USD, RSI 64.8, 52w range 21.8 USD–31.34 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is ZYME in?

Zymeworks (ZYME) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is ZYME in an uptrend or downtrend?

As of 2026-10-26, ZYME is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is ZYME's trailing P/E ratio?

ZYME's trailing P/E is -17.06, with a market cap of 1.73B. See the earnings research page for full valuation detail.

When does ZYME next report earnings?

ZYME is next scheduled to report earnings on 2026-08-06.